The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Current developments of coumarin-based anti-cancer agents in medicinal chemistry
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,633
Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities
Fylaktakidou, K., Hadjipavlou-Litina, D., Litinas, K., & Nicolaides, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382710 · Cited by 970
Coumarins : biology, applications, and mode of action
O’Kennedy, R. J., & THORNES, R. D. (1997) · Medical Entomology and Zoology · Cited by 959
Chiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2470 · Cited by 750
Kapoor, T. M., Mayer, T. U., Coughlin, M. L., & Mitchison, T. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.975 · Cited by 717
Derivation and Validation of Toxicophores for Mutagenicity Prediction
Kazius, J., McGuire, R., & Bursi, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040835a · Cited by 666
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Current Developments of Coumarin Compounds in Medicinal Chemistry
Peng, X.-M., L.V. Damu, G., & He Zhou, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319210013 · Cited by 504
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Kostova, I., Bhatia, S., Grigorov, P., Balkansky, S., S. Parmar, V., K. Prasad, A., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414395 · Cited by 435
The when and wheres of CDC25 phosphatases
Boutros, R., Dozier, C., & Ducommun, B. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.02.003 · Cited by 414
Riedl, S., Zweytick, D., & Lohner, K. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.09.004 · Cited by 405
Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent Signaling Proteins
Marcu, M. G., Schulte, T. W., & Neckers, L. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.242 · Cited by 405
Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins
Maresca, A., Temperini, C., Pochet, L., Masereel, B., Scozzafava, A., & Supuran, C. T. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901287j · Cited by 402
Anticancer activity of new coumarin substituted hydrazide–hydrazone derivatives
Nasr, T., Bondock, S., & Youns, M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.026 · Cited by 334
Terzioğlu, N., & Gürsoy, A. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00138-7 · Cited by 324
Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Roupe, K., Remsberg, C., Yanez, J., & Davies, N. (2006) · Current Clinical Pharmacology · doi:10.2174/157488406775268246 · Cited by 309
Cellular senescence as a tumor-protection mechanism: the essential role of counting
Wright, W. E., & Shay, J. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00163-5 · Cited by 306
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
Potter, C. P. S., & Harris, A. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600936 · Cited by 300
Reactions of Alpha Methylene Lactone Tumor Inhibitors with Model Biological Nucleophiles
Kupchan, S. M., Fessler, D. C., Eakin, M. A., & Giacobbe, T. J. (1970) · Science · doi:10.1126/science.168.3929.376 · Cited by 298
Dörrie, J., Gerauer, H., Wachter, Y., & Zunino, S. J. (2001) · PubMed · Cited by 294
Synthesis and in vitro evaluation of novel coumarin–chalcone hybrids as potential anticancer agents
Sashidhara, K. V., Kumar, A., Kumar, M., Sarkar, J., & Sinha, S. K. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.116 · Cited by 290
The Structure and Pharmacological Functions of Coumarins and Their Derivatives
Wu, L., Wang, X., Xu, W., Farzaneh, F., & Xu, R. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789578187 · Cited by 289
Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
Bailly, C. (2012) · Chemical Reviews · doi:10.1021/cr200325f · Cited by 288
Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
Keri, R. S., B.S., S., Nagaraja, B. M., & Santos, M. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.017 · Cited by 271
Sale, S., Verschoyle, R. D., Boocock, D., Jones, D. J. L., Wilsher, N., Ruparelia, K. C., Potter, G. A., Farmer, P. B., Steward, W. P., & Gescher, A. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601568 · Cited by 260
Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., Kakudo, Y., Takahashi, A., Takahashi, S., Kato, S., Suzuki, T., Ishioka, C., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0174 · Cited by 242
K-ras as a target for cancer therapy
Friday, B. B., & Adjei, A. A. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.001 · Cited by 241
Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D., Ward, R., Wilson, R. H., Stanczyk, F. Z., Dobbs, N., Kulinskaya, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1996 · Cited by 238
Lamellarin D: a novel potent inhibitor of topoisomerase I.
Facompré, M., Tardy, C., Mahieu, C., Colson, P., Perez, C., Manzanares, I., Cuevas, C., & Bailly, C. (2003) · PubMed · Cited by 238
Belluti, F., Fontana, G., Bo, L. D., Carenini, N., Giommarelli, C., & Zunino, F. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.069 · Cited by 232
Abadi, A., Eissa, A. A. H. M., & Hassan, G. S. (2003) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.51.838 · Cited by 221
Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro
Rivière, C., Richard, T., Quentin, L., Krisa, S., Mérillon, J.-M., & Monti, J.-P. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.069 · Cited by 214
Braulio Insuasty, O., Tigreros, A., Orozco, F., Jairo Quiroga, P., Abonía, R., Nogueras, M., Sánchez, A., & Cobo, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.013 · Cited by 212
Resveratrol and cancer: a review
Savouret, J. F., & Quesne, M. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00158-5 · Cited by 209
Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual Screening
Ostrov, D. A., Hernández Prada, J. A., Corsino, P. E., Finton, K. A., Le, N., & Rowe, T. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00392-07 · Cited by 204
Therapeutic Protein Kinase Inhibitors
Grant, S. K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8539-7 · Cited by 194
Zhang, W., Li, Z., Zhou, M., Wu, F. Y., Hou, X., Luo, H., Liu, H., Han, X., Yan, G., Ding, Z., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.095 · Cited by 165
Sale, S., Tunstall, R. G., Ruparelia, K. C., Potter, G. A., Steward, W. P., & Gescher, A. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20884 · Cited by 165
Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity
Reddy, N. S., Mallireddigari, M. R., Cosenza, S., Gumireddy, K., Bell, S. C., Reddy, E. P., & Reddy, M. V. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.016 · Cited by 165
Structure of histone acetyltransferases 1 1Edited by P. W. Wright
Marmorstein, R. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4859 · Cited by 163
The Interaction of Coumarin Antibiotics with Fragments of the DNA Gyrase B Protein
Gormley, N. A., Orphanides, G., Meyer, A., Cullis, P. M., & Maxwell, A. (1996) · Biochemistry · doi:10.1021/bi952888n · Cited by 163
Tolomeo, M., Grimaudo, S., Cristina, A. D., Roberti, M., Pizzirani, D., Meli, M., Dusonchet, L., Gebbia, N., Abbadessa, V., Crosta, L., et al. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.03.004 · Cited by 161
Discovery and synthesis of novel 3-phenylcoumarin derivatives as antidepressant agents
Sashidhara, K. V., Kumar, A., Chatterjee, M., Rao, K. B., Singh, S., Verma, A. K., & Palit, G. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.040 · Cited by 150
Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity
Paul, K., Bindal, S., & Luxami, V. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.12.071 · Cited by 140
Amin, K. M., Eissa, A. A. M., Abou‐Seri, S. M., Awadallah, F. M., & Hassan, G. S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.004 · Cited by 136
Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives
Stanchev, S., Momekov, G., Jensen, F., & Manolov, I. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.05.005 · Cited by 135
Synthesis and Biological Evaluation of 4-Arylcoumarin Analogues of Combretastatins. Part 2
Combes, S., Barbier, P., Douillard, S., Leer, A. M., Bourgarel‐Rey, V., Pierson, J., Fedorov, A. Y., Finet, J., Boutonnât, J., & Peyrot, V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm901826e · Cited by 128
An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin
Marshall, M. E., Mohler, J. L., Edmonds, K., Williams, B. R., Butler, K. M., Ryles, M., Weiss, L., Urban, D. A., Bueschen, A. J., Markiewicz, M., et al. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377124 · Cited by 125
Synthesis and Biological Evaluation of 4-Arylcoumarin Analogues of Combretastatins
Bailly, C., Bal, C., Barbier, P., Combes, S., Finet, J., Hildebrand, M., Peyrot, V., & Wattez, N. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030903d · Cited by 124
Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors
Razavi, S. F., Khoobi, M., Nadri, H., Sakhteman, A., Moradi, A., Emami, S., Foroumadi, A., & Shafiee, A. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.021 · Cited by 122
Self-citationPancreatic anticancer activity of a novel geranylgeranylated coumarin derivative
Devji, T. F., Reddy, C., Woo, C. M., Awale, S., Kadota, S., & Carrico-Moniz, D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.005 · Cited by 121
Novel bis(indolyl)hydrazide–hydrazones as potent cytotoxic agents
Kumar, D., Kumar, N., Ghosh, S., & Shah, K. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.031 · Cited by 121
Kim, H. J., Jang, S. I., Kim, Y., Chung, H.-T., Yong-Gab, Y., Kang, T.-H., Jeong, O.-S., & Kim, Y.-C. (2004) · Fitoterapia · doi:10.1016/j.fitote.2003.12.021 · Cited by 118
Asadipour, A., Alipour, M., Jafari, M., Khoobi, M., Emami, S., Nadri, H., Sakhteman, A., Moradi, A., Sheibani, V., Moghadam, F. H., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.024 · Cited by 115
Self-citationInduction of apoptosis by esculetin in human leukemia cells
Chu, C.-Y., Tsai, Y.-Y., Wang, C., Lin, W., & Tseng, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00859-7 · Cited by 109
Epigenomics of leukemia: from mechanisms to therapeutic applications
Florean, C., Schnekenburger, M., Grandjenette, C., Dicato, M. A., & Diederich, M. F. (2011) · Epigenomics · doi:10.2217/epi.11.73 · Cited by 108
The aminocoumarins: biosynthesis and biology
Heide, L. E. (2009) · Natural Product Reports · doi:10.1039/b808333a · Cited by 105
Douglas, N. R., Reißmann, S., Zhang, J., Chen, B., Jakana, J., Kumar, R. N., Chiu, W., & Frydman, J. (2011) · Cell · doi:10.1016/j.cell.2010.12.017 · Cited by 104
Atmaca, M., Bilgin, H. M., Obay, B. D., et al. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0103-5 · Cited by 103
Proton transport inhibitors as potentially selective anticancer drugs.
Harguindey, S., Arranz, J. L., Wahl, M., Orive, G., & Reshkin, S. J. (2009) · PubMed · Cited by 101
Awale, S., Nakashima, E. M. N., Kalauni, S. K., Tezuka, Y., Kurashima, Y., Lu, J., Esumi, H., & Kadota, S. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.046 · Cited by 94
Novel coumarin-dihydropyrazole thio-ethanone derivatives: Design, synthesis and anticancer activity
Wu, X., Huang, C. Z., Jia, Y., Song, B.-A., Li, J., & Liu, X. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.014 · Cited by 92
Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives
Alipour, M., Khoobi, M., Moradi, A., Nadri, H., Moghadam, F. H., Emami, S., Hasanpour, Z., Foroumadi, A., & Shafiee, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.056 · Cited by 91
Self-citationVijayaraghavalu, S., Peetla, C., Lu, S., & Labhasetwar, V. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300281t · Cited by 85
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives
Congiu, C., Onnis, V., Vesci, L., Castorina, M., & Pisano, C. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.07.037 · Cited by 76
Barros, T. A. D. A., Freitas, L., Barbosa‐Filho, J. M., Nunes, X. P., Giulietti, A. M., de Souza, G. E. P., dos Santos, R. R., Soares, M. B. P., & Villarreal, C. F. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.02.0008 · Cited by 75
Yang, J., Liu, G., Dai, F., Cao, X., Kang, Y., Hu, L., Tang, J., Li, X., Li, Y., Jin, X., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.090 · Cited by 75
Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells
Saidu, N. E. B., Valente, S., Bana, É., Kirsch, G., Bagrel, D., & Montenarh, M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.032 · Cited by 74
Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors
Han, S., Zhou, V. W., Pan, S., Liu, Y., Hornsby, M. J., McMullan, D., Klock, H. E., Haugen, J., Lesley, S. A., Gray, N. S., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.097 · Cited by 73
Draoui, N., Schicke, O., Fernandes, A. E., Drozak, X., Nahra, F., Dumont, A. O., Douxfils, J., Hermans, E., Dogné, J., Corbau, R., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.010 · Cited by 72
Hua, C., Li, S., Yao, Y., Zhou, L., Zhao, J., Gu, Y., Wang, K., & Li, X. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.07.009 · Cited by 69
Lopez, M., Bornaghi, L. F., Innocenti, A., Vullo, D., Charman, S. A., Supuran, C. T., & Poulsen, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901888x · Cited by 68
Wang, Z., Qin, Y.-J., Wang, P., Yang, Y.-A., Wen, Q., Zhang, X., Qiu, H., Duan, Y., Wang, Y., Sang, Y.-L., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.035 · Cited by 65
Khoobi, M., Emami, S., Dehghan, G., Foroumadi, A., Ramazani, A., & Shafiee, A. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201000271 · Cited by 63
Self-citationWoo, L. W. L., Ganeshapillai, D., THOMAS, M. P., Sutcliffe, O. B., Malini, B., Mahon, M. F., Purohit, A., & Potter, B. V. L. (2011) · ChemMedChem · doi:10.1002/cmdc.201100288 · Cited by 62
Multifactorial nature of tumor drug resistance.
Solyanik, G. I. (2010) · PubMed · Cited by 60
RAS/RAF/MEK Inhibitors in Oncology
Broggini, M. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320510 · Cited by 60
Differential effects of monastrol in two human cell lines
Leizerman, I., Avunie-Masala, R., Elkabets, M., Fich, A., & Gheber, L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4074-3 · Cited by 56
Discovery and structure?activity relationship of coumarin derivatives as TNF-$alpha; inhibitors
Cheng, J., Chen, M., Wallace, D., Tith, S., Arrhenius, T. S., Kashiwagi, H., Ono, Y., Ishikawa, A., Sato, H., Kozono, T., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(04)00355-5 · Cited by 54
Bagheri, S. M., Khoobi, M., Nadri, H., Moradi, A., Emami, S., Jalili‐Baleh, L., Jafarpour, F., Moghadam, F. H., Foroumadi, A., & Shafiee, A. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12588 · Cited by 53
Self-citationWarfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth
McCulloch, P. G., & George, W. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.37 · Cited by 50
Seidel, C., Schnekenburger, M., Zwergel, C., Gaascht, F., Mai, A., Dicato, M. A., Kirsch, G., Valente, S., & Diederich, M. F. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.067 · Cited by 48
Ruiz-Marcial, C., Reyes‐Chilpa, R., Estrada, E., Reyes-Esparza, J. A., Fariña, G. I. G., & Rodríguez‐Fragoso, L. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.5.0013 · Cited by 46
El-Gamal, M. I., & Oh, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.064 · Cited by 45
Kempen, I., Hemmer, M., Counerotte, S., Pochet, L., Tullio, P. D., Foidart, J., Blacher, S., Noël, A., Frankenne, F., & Pirotte, B. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.01.024 · Cited by 45
Harada, K., Kubo, H., Tomigahara, Y., Nishioka, K., Takahashi, J., Momose, M., Inoue, S., & Kojima, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.111 · Cited by 44
Fink, B. E., Gavai, A. V., Tokarski, J. S., Goyal, B., Misra, R. N., Xiao, H., Kimball, S. D., Han, W.-C., Norris, D. J., Spires, T. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.039 · Cited by 40
Design, Synthesis, and Anticancer Properties of Novel Benzophenone‐Conjugated Coumarin Analogs
Ranganatha, V. L., Zameer, F., Meghashri, S., Rekha, N. D., Girish, V., Gurupadaswamy, H. D., & Khanum, S. A. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300298 · Cited by 38
Lead identification of a potent benzopyranone selective estrogen receptor modulator
McKie, J. A., Bhagwat, S. S., Brady, H. A., Doubleday, M., Gayo, L. M., Hickman, M., Jalluri, R. K., Khammungkhune, S., Kois, A., Mortensen, D. S., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.081 · Cited by 38
Липеева, А. В., Pokrovsky, M. A., Baev, D. S., Shakirov, M. M., Bagryanskaya, I. Y., Tolstikova, T. G., Pokrovsky, А. G., & Shults, E. E. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.016 · Cited by 36
Bana, É., Sibille, E., Valente, S., Cerella, C., Chaimbault, P., Kirsch, G., Dicato, M. A., Diederich, M. F., & Bagrel, D. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22094 · Cited by 36
The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors
Vicker, N., Sharland, C. M., Heaton, W. B., Ramos, A., Bailey, H. V., Smith, A. C., Springall, J. S., Day, J. M., Tutill, H. J., Reed, M. J., et al. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.005 · Cited by 30
Xiao, C. F., Tao, L., Sun, H. Y., Wei, W., Chen, Y., Fu, L., & Zou, Y. (2010) · Chinese Chemical Letters · doi:10.1016/j.cclet.2010.04.034 · Cited by 26
Melena, J., Safa, R., Graham, M., Casson, R. J., & Osborne, N. N. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03375-4 · Cited by 24
Aoki, T., Hyohdoh, I., Furuichi, N., Ozawa, S., Watanabe, F., Matsushita, M., Sakaitani, M., Ori, K., Takanashi, K., Harada, N., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.001 · Cited by 22
Cited by
Coumarin-Based Small-Molecule Fluorescent Chemosensors
Cao, D., Liu, Z., Verwilst, P., Koo, S., Jangjili, P., Kim, J. S., & Lin, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00145 · Cited by 1,306
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 565
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Dadashpour, S., & Emami, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.065 · Cited by 343
Self-citation
Metadata
- Authors
- Emami, S., & Dadashpour, S.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 102
- Pages
- 611-630
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1161204293
- Cited by
- 504
- References
- 101
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.